Merck Tbk. vs Wahana Inti Makmur Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Wahana Inti Makmur Tbk. trades at Rp121 (market cap 96.08B, 1.91M 24h volume). The key difference: Merck Tbk. is far larger — about 17.7× Wahana Inti Makmur Tbk.'s market cap, and Wahana Inti Makmur Tbk. is more actively traded (1.91M versus 37.6K). Which is the better fit depends on your goals.
| MERK | NASI | |
|---|---|---|
Market Cap | 1.7T | 96.08B |
Volume | 37.6K | 1.91M |
Lot | 376 | 19.12K |
Turnover | 144.47M | 228.71M |
Average Price | 3,842.23 | 119.64 |
Value | 144.47M | 228.71M |
Indicative Equilibrium Price | 3,840 | 121 |
Indicative Equilibrium Volume | 7 | 200 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Wahana Inti Makmur Tbk (the Company) is established based on Deed of Establishment No. 02 dated February 14, 2015 made by Dr. Tio Jeffrens Maranella, S.H., Notary in Jakarta. The Company started its commercial operations in February 2015.
Read more on NASI →